Dec 05,2023

The ALS Association and NuvoAir Partner to Launch First-Ever Virtual Pulmonary Care for ALS patients

The ALS Association, the largest philanthropic funder of ALS research, and NuvoAir announced their partnership to support virtual pulmonary care for people living with ALS and their caregivers. The partnership is part of the ALS Association’s plan to bring high-quality pulmonary care to all those living with ALS. The partnership launches with two ALS clinics in Texas, Texas Neurology and the University of Texas Health Science Center, with the imperative support of Respiratory Quality Services, a Texas-based company providing in-person respiratory therapy.

COLLABORATION PARTNERSHIP

#institution

View Analyst & Ambassador Comments
Go to original news
Feb 27,2024

Mynd Immersive Launches XR Therapy program for Native American Seniors

Mynd Immersive (fka. MyndVR) has announced its partnership with Cherokee Elder Care (CEC) in Tahlequah, Oklahoma. CEC is a non-profit entity of the Cherokee Nation, providing a long-term care option for anyone that meets the qualifications. Individuals do not have to be Native American to qualify. This marks the first time the CEC has implemented any form of VR therapy for its seniors. 

COLLABORATION PARTNERSHIP

#institution

#virtual reality

View Analyst & Ambassador Comments
Go to original news
Feb 26,2024 TOP STORY

GE HealthCare and Biofourmis Collaborate to Extend Patient Monitoring Outside the Hospital with Virtual Care-at-Home Solutions

GE HealthCare and Biofourmis have announced a strategic collaboration aimed at enhancing continuity of care by enabling safe, effective, and accessible care in the home to support the patient journey beyond the hospital setting. The goal of the GE HealthCare-Biofourmis collaboration is to enable more patients to go home earlier, and offer an alternative to facility-based care with the comfort and peace of mind that they are receiving high quality care at home. GE HealthCare’s FlexAcuity™ monitoring solutions in combination with GE HealthCare’s virtual care solutions like Mural ICU, Command Center and Digital CMU adapt to rapidly changing patient needs in the hospital and are built on a legacy of innovation. By offering Biofourmis’ virtual care-at-home solutions to customers, GE HealthCare can extend the care continuum beyond the hospital, and care teams can have a longitudinal patient view beyond the hospital setting. GE HealthCare will begin distributing Biofourmis solutions to customers in the United States starting Q1 2024.

COLLABORATION PARTNERSHIP

#institution

#virtual care

#rpm

View Analyst & Ambassador Comments
Go to original news
Feb 20,2024

Blackford and b-rayZ Announce Commercial Partnership

Blackford, the pioneering strategic AI platform and solutions provider, and b-rayZ, a Swiss AI powered breast diagnostics provider, announced a commercial partnership to bring the b-box plus solution to healthcare professionals. Under the partnership, b-rayZ's innovative technology will be integrated with Blackford's enterprise AI platform. By integrating b-rayZ’s advanced technology into the Blackford Platform, Blackford can offer healthcare providers powerful tools for breast cancer detection, density assessment, breast position quality, and workflow optimization.

COLLABORATION PARTNERSHIP

#institution

#ai/software

View Analyst & Ambassador Comments
Go to original news
Feb 06,2024 TOP STORY

Better Therapeutics Signs Rebate Agreement with One of the Largest Pharmacy Benefit Managers in the US for its AspyreRx Diabetes Treatment

Better Therapeutics announced that it has entered into a rebate agreement with one of the nation’s leading Pharmacy Benefit Managers (PBMs) negotiating on behalf of over 70 million lives in the US. The rebate agreement, effective January 1, 2024, applies to the PBM’s commercial book of business and provides plan participants of the PBM the ability to add AspyreRx™ to their formularies with rebate eligibility. The company continues to engage with national and regional health plans, as well as Pharmacy Benefit Managers (PBMs) and Group Purchasing Organizations (GPOs), to communicate the value of AspyreRx for patients with T2D and to secure broad coverage.

COLLABORATION PARTNERSHIP

#institution

#pdt

View Analyst & Ambassador Comments
Go to original news
Feb 06,2024

Better Therapeutics Signs Rebate Agreement with One of the Largest Pharmacy Benefit Managers in the US for its AspyreRx Diabetes Treatment

Better Therapeutics announced that it has entered into a rebate agreement with one of the nation’s leading Pharmacy Benefit Managers (PBMs) negotiating on behalf of over 70 million lives in the US. The rebate agreement, effective January 1, 2024, applies to the PBM’s commercial book of business and provides plan participants of the PBM the ability to add AspyreRx™ to their formularies with rebate eligibility. The company continues to engage with national and regional health plans, as well as Pharmacy Benefit Managers (PBMs) and Group Purchasing Organizations (GPOs), to communicate the value of AspyreRx for patients with T2D and to secure broad coverage.

COLLABORATION PARTNERSHIP

#institution

#dtx

View Analyst & Ambassador Comments
Go to original news
Jan 30,2024 TOP STORY

Reimagine Care and Michiana Hematology Oncology Partnership Extends Cancer Care into the Homes of Patients of the Largest Cancer Provider in the Region

Reimagine Care, the nation’s leading provider of virtual-first cancer care, announces a partnership with Michiana Hematology Oncology (MHO) to extend its cancer care services beyond the walls of the clinic. This partnership represents a significant step towards a more patient-centric treatment experience by integrating clinical oncology experts with technology to support MHO’s patients around the clock. By combining Reimagine Care's virtual, digital, and data capabilities with MHO's expertise in hematology and oncology, the collaboration aims to break down barriers to access and transform the way patients receive treatment. MHO patients will have the ability discuss treatment plans, ask questions, manage symptoms, and receive personalized care with Reimagine Care’s oncology advanced practice providers and registered nurses through SMS text, call, and video consultations.

COLLABORATION PARTNERSHIP

#institution

#virtual care

#rpm

View Analyst & Ambassador Comments
Go to original news
Jan 31,2024 TOP STORY

VBC enabler Valendo Health launches for endocrinologists to provide 'across the board' diabetes care

A new value-based care enabler Valendo Health focused on endocrinology has launched with a mission to shape the future of diabetes care. Valendo Health uses a phased approach to offer expertise, technology and data-rich tools to help independent physicians enhance clinical capacity, streamline operations and transition to value-based care. The startup has announced two initial provider partners: Cecelia Health, a virtual provider for chronic care management, and Advanced Metabolic Care + Research (AMCR), an endocrinology center in Southern California. Through its partnership with Cecelia, Valendo can offer practices like AMCR access to multilingual diabetes educators, nutritionists, nurses and other clinicians “to make sure we can provide care across the board in every community across the country,” CEO Dave Terry said. To date, Cecelia has contracted with large payers, health system and pharma companies—not smaller practices like ACMR. Valendo is now helping it to do so and to learn about the risk-taking business should it decide to pursue value-based arrangements in the future.

COLLABORATION PARTNERSHIP

#institution

#telehealth

#rpm

View Analyst & Ambassador Comments
Go to original news
Jan 31,2024 TOP STORY

Trinity Biotech Announces Entry into a Letter of Intent with Bayer for a Joint Partnership to Launch a CGM Biosensor Device in China and India

Trinity Biotech announced that it has entered into a non-binding Letter of Intent with Bayer for the launch of a Continuous Glucose Monitoring biosensor device in China and India. This Letter of Intent is related to Trinity’s recently announced acquisition of the CGM assets of Waveform Technologies, Inc. Both parties intend to negotiate a definitive agreement under the framework set by the Letter of Intent in the coming months. The China Joint Partnership intends to leverage Bayer's significant and well-established presence in the Chinese healthcare market, particularly in diabetes, and is intended to lead to the launch of a low cost of care, high quality, CGM device designed to increase affordability and accessibility of diabetes care. To date, CGM use in India is not widespread, but has been trending higher recently with increasing awareness about self-care. Bayer Pharma India has a strong presence in the diabetes market with brands like Kerendia® and Glucobay®.

COLLABORATION PARTNERSHIP

#institution

#cgm

View Analyst & Ambassador Comments
Go to original news
Jan 05,2024

Blackford and Rayscape Announce Commercial Partnership

Blackford and Rayscape today announced a commercial partnership to bring the Rayscape CXR and Rayscape Lung CT solutions to healthcare professionals. Under the partnership, Rayscape's innovative technology will be integrated with Blackford's enterprise AI platform. Rayscape Lung CT leverages the power of AI to empower lung cancer detection and management. From detecting pulmonary nodules to precise localization, comprehensive analysis, and automatic comparisons across follow-up investigations, this solution seamlessly integrates into existing workflow, providing radiologists with an end-to-end solution for lung cancer detection and monitoring.

COLLABORATION PARTNERSHIP

#institution

#ai/software

View Analyst & Ambassador Comments
Go to original news
Subscribe to INSTITUTION